Stay updated on Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.2 to v3.6.3, signaling a small internal release rather than a change to the study details or how a user interacts with the page.
    Difference
    0.1%
    Check dated 2026-07-04T13:28:38.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing Revision: v3.6.0, indicating a minor update to the page's revision history rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-27T05:55:12.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Recruitment status is updated to 'No longer looking for participants', indicating the study is not enrolling any more participants. Additional navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions/Treatment header formatting plus a revision label update (v3.6.0) were applied.
    Difference
    0.4%
    Check dated 2026-06-13T04:41:15.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page shows a new deployment revision number, updating from v3.5.4 to v3.5.5. This change does not affect the study details or other visible content on the page.
    Difference
    0.1%
    Check dated 2026-06-05T21:44:14.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4 at the bottom, replacing Revision: v3.5.3, indicating a recent site update or release without modifying the study content.
    Difference
    0.1%
    Check dated 2026-05-15T14:23:57.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The webpage’s footer revision version is updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:25:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.